White Paper

Pharmacy Services In A Phase I Clinical Research Unit

By Sherilyn Adcock, Ph.D., George Atiee, M.D., John Sramek, Pharm.D.

Pharmacy Services In A Phase I Clinical Research Unit

Phase I clinical studies form an important foundation for drug development and eventual approval of life-saving therapies. Potential drug candidates are screened for entry into Phase I trials by extensive in-vitro testing and tolerance in several animal species. Early in-vitro testing establishes potential mechanisms of action, such as binding to a receptor or enzyme. Animal toxicology at large doses is used to determine a small, safe starting dose for first-in- human trials. This article reviews the role of the pharmacy in a modern Phase I clinical research unit (CRU). In light of limited published literature about pharmacy services in a Phase I setting, this article explores the inner workings of a highly active pharmacy unit.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: